Maravai LifeSciences Holdings, Inc. MRVI Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Maravai LifeSciences Holdings, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s return on equity?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported return on equity of -40.8% in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s return on equity changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s return on equity increased by 10.8% year-over-year, from -45.8% to -40.8%.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s return on equity?
- Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s return on equity has grown at a -14.3% compound annual growth rate (CAGR), from 90.1% to -48.6%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.